A growing number of clinicians rely on AdaptDx to detect age-related macular degeneration in their adult patients. Our customers tell the story of how they’re fighting against blindness caused by AMD.
After five years of using the AdaptDx to identify AMD at its earliest stage and then placing patients on a treatment regimen involving modifiable risk factors, I have documented many patients having improved Rod Intercept times (improved dark adaptation) and maintaining their visual acuity.
I feel that the AdaptDx instrument from MacuLogix is the most significant diagnostic breakthrough in my career! We finally have an instrument that helps us diagnose AMD before vision loss occurs!
When I look at the future of managing macular degeneration, I see the AdaptDx as the essential tool in AMD management just as now I see the OCT as the essential tool in managing glaucoma in its earliest stages. By finding a disease early, and intervening appropriately we have the best chance of altering the course.